Solving Genetic Diseases??? Dr. Neil Kumar, Founder & CEO, BridgeBio Pharma

07/03/24 • 23 min

This week on Biotech Nation, Dr. Neil Kumar, founder and CEO of BridgeBio Pharma. Dr. Kumar emphasizes that genetic diseases, particularly Mendelian diseases caused by single gene mutations, are solvable due to advancements in genetic measurement and understanding. He discusses BridgeBio Pharma's innovative corporate structure, which consists of multiple specialized companies under a centralized infrastructure to efficiently tackle various genetic diseases. This model allows for focused expertise on individual conditions while sharing common resources. Dr. Kumar highlights the company's commitment to using diverse therapeutic modalities, such as small molecules and gene therapies, to develop treatments that address the underlying causes of these diseases.

07/03/24 • 23 min

BioTech Nation ... with Dr. Moira Gunn - Solving Genetic Diseases??? Dr. Neil Kumar, Founder & CEO, BridgeBio Pharma

Transcript

Dr. Moira Gunn00:00:11.704

When I originally spoke with doctor Neil Kumar, the founder and CEO of Bridge Biopharma, he was very direct. Genetic diseases are solvable. Today, we'll hear from doctor Kumar about what he means and about the innovative corporate structure of Bridge BioPharma itself designed for innovation and success. Doctor Kumar, welcome back to the program.

Dr. Neil Kumar00:00:37.598

Thank you so much for having me again.

Generate a badge

Get a badge for your website that links back to this episode

Select type & size

Copy